Lv1
10 积分 2025-05-17 加入
Consensus guidelines and recommendations for the management and response assessment of chimeric antigen receptor T-cell therapy in clinical practice for relapsed and refractory multiple myeloma: a report from the International Myeloma Working Group Immunotherapy Committee
13小时前
已完结
Daratumumab or Active Monitoring for High-Risk Smoldering Multiple Myeloma
13小时前
已完结
High‐risk multiple myeloma: Redefining genetic, clinical, and functional high‐risk disease in the era of molecular medicine and immunotherapy
13小时前
已完结
皖公网安备34019202002308
